These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 37475553

  • 1. The Role of Hypoxia-inducible Factor-1 in Bladder Cancer.
    Chai J, Yin S, Feng W, Zhang T, Ke C.
    Curr Mol Med; 2024; 24(7):827-834. PubMed ID: 37475553
    [Abstract] [Full Text] [Related]

  • 2. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
    Chen MC, Hsu WL, Chang WL, Chou TC.
    Sci Rep; 2017 Jul 14; 7(1):5376. PubMed ID: 28710377
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
    Xue M, Li X, Chen W.
    Mol Med Rep; 2015 Aug 14; 12(2):2121-7. PubMed ID: 25824695
    [Abstract] [Full Text] [Related]

  • 4. The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.
    Zuo Y, Qu C, Tian Y, Wen Y, Xia S, Ma M.
    Biofactors; 2021 May 14; 47(3):444-460. PubMed ID: 34003544
    [Abstract] [Full Text] [Related]

  • 5. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y.
    Urol Int; 2012 May 14; 88(1):95-101. PubMed ID: 22041818
    [Abstract] [Full Text] [Related]

  • 6. A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.
    Cesário JM, Brito RB, Malta CS, Silva CS, Matos YS, Kunz TC, Urbano JJ, Oliveira LV, Dalboni MA, Dellê H.
    In Vitro Cell Dev Biol Anim; 2017 Mar 14; 53(3):272-276. PubMed ID: 27752923
    [Abstract] [Full Text] [Related]

  • 7. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
    Kondo Y, Hamada J, Kobayashi C, Nakamura R, Suzuki Y, Kimata R, Nishimura T, Kitagawa T, Kunimoto M, Imura N, Hara S.
    J Urol; 2005 May 14; 173(5):1762-6. PubMed ID: 15821583
    [Abstract] [Full Text] [Related]

  • 8. Targeting hypoxia and angiogenesis through HIF-1alpha inhibition.
    Diaz-Gonzalez JA, Russell J, Rouzaut A, Gil-Bazo I, Montuenga L.
    Cancer Biol Ther; 2005 Oct 14; 4(10):1055-62. PubMed ID: 16294030
    [Abstract] [Full Text] [Related]

  • 9. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Miyake M, Fujimoto K, Anai S, Ohnishi S, Kuwada M, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Tanaka N, Hirao Y.
    Oncol Rep; 2011 Mar 14; 25(3):653-60. PubMed ID: 21206978
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer.
    Qing L, Li Q, Yang Y, Xu W, Wang Y, Li R, You C, Dong Z.
    Mol Carcinog; 2024 Jul 14; 63(7):1303-1318. PubMed ID: 38634741
    [Abstract] [Full Text] [Related]

  • 11. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A, Fujiyama C, Blanche C, Moore JW, Fuggle S, Cranston D, Bicknell R, Harris AL.
    Clin Cancer Res; 2001 May 14; 7(5):1263-72. PubMed ID: 11350893
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
    Theodoropoulos VE, Lazaris ACh, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, Manikas K, Kastriotis I.
    Eur Urol; 2004 Aug 14; 46(2):200-8. PubMed ID: 15245814
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
    Roda JM, Sumner LA, Evans R, Phillips GS, Marsh CB, Eubank TD.
    J Immunol; 2011 Aug 15; 187(4):1970-6. PubMed ID: 21765015
    [Abstract] [Full Text] [Related]

  • 14. Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.
    Pourgholami MH, Cai ZY, Badar S, Wangoo K, Poruchynsky MS, Morris DL.
    BMC Cancer; 2010 Apr 15; 10():143. PubMed ID: 20398289
    [Abstract] [Full Text] [Related]

  • 15. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M, Ozaki T, Sun D, Xing H, Wei B, An J, Yang J, Gao Y, Liu S, Kong C, Zhu Y.
    J Exp Clin Cancer Res; 2020 Jun 10; 39(1):108. PubMed ID: 32522234
    [Abstract] [Full Text] [Related]

  • 16. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
    Chen MC, Hsu WL, Hwang PA, Chou TC.
    Mar Drugs; 2015 Jul 17; 13(7):4436-51. PubMed ID: 26193287
    [Abstract] [Full Text] [Related]

  • 17. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
    Ban HS, Kim BK, Lee H, Kim HM, Harmalkar D, Nam M, Park SK, Lee K, Park JT, Kim I, Lee K, Hwang GS, Won M.
    Cell Death Dis; 2017 Jun 01; 8(6):e2843. PubMed ID: 28569777
    [Abstract] [Full Text] [Related]

  • 18. Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer.
    Song IS, Wang AG, Yoon SY, Kim JM, Kim JH, Lee DS, Kim NS.
    Exp Mol Med; 2009 Jan 31; 41(1):51-8. PubMed ID: 19287200
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.